Psychotropics India Profile
Key Indicators
- Authorised Capital ₹ 15.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 10.50 Cr
as on 24-10-2024
- Company Age 38 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 84.22 Cr
as on 24-10-2024
- Satisfied Charges ₹ 63.60 Cr
as on 24-10-2024
About Psychotropics India
The Corporate was formerly known as Psychotropics India Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 10.50 Cr.
The company currently has active open charges totaling ₹84.22 Cr. The company has closed loans amounting to ₹63.60 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Psychotropics India Limited India are Kirti Kathuria as Company Secretary, Kirti Kathuria as Company Secretary, and Amit Pushpakar as Cfo. Anand Jain, Sajan Jain, Navdeep Chawla, and Two other members serve as directors at the Company.
- CIN/LLPIN
U85194HR1986PLC071264
- Company No.
071264
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
08 Jul 1986
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Faridabad, Haryana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Psychotropics India Limited offer?
Psychotropics India Limited offers a wide range of products and services, including Herbal Soaps, Aloe Vera Soap, Cholesterol Medicine, Atorvastatin Tablet, Antipyretic Medication, Paracetamol Tablets, Kitchen Utensil, Stainless Steel Utensils, Anti Allergic Drug, Hair Soap.
Who are the key members and board of directors at Psychotropics India?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Siddharth Chawla  | Managing Director | 31-Mar-2006 | Current |
| Kirti Kathuria | Company Secretary | Current | |
| Amit Pushpakar | CFO | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Navdeep Chawla | Whole-Time Director | 18-Dec-1996 | Current |
| Anand Jain | Additional Director | 12-Apr-2024 | Current |
| Sajan Jain | Director | 16-Dec-2014 | Current |
| Amita Chawla | Whole-Time Director | 31-Dec-2008 | Current |
Financial Performance of Psychotropics India.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Psychotropics India?
Unlock access to Psychotropics India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Pil Pharmaceuticals LimitedActive 17 years 7 monthsNavdeep Chawla, Siddharth Chawla and 1 more are mutual person
Faridabad Industries AssociationActive 9 years 7 monthsSajan Jain and Navdeep Chawla are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 25 Jul 2024 | ₹15.00 Cr | Open |
Others Creation Date: 26 Apr 2024 | ₹8.00 Cr | Open |
Axis Bank Limited Creation Date: 27 Nov 2023 | ₹9.93 M | Open |
How Many Employees Work at Psychotropics India?
Unlock and access historical data on people associated with Psychotropics India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Psychotropics India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Psychotropics India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
